Search Results - "NZILA, A. M"

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Towards an Understanding of the Mechanism of Pyrimethamine-Sulfadoxine Resistance in Plasmodium falciparum: Genotyping of Dihydrofolate Reductase and Dihydropteroate Synthase of Kenyan Parasites by NZILA, A. M, MBERU, E. K, SULO, J, DAYO, H, WINSTANLEY, P. A, SIBLEY, C. H, WATKINS, W. M

    Published in Antimicrobial Agents and Chemotherapy (01-04-2000)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  2. 2

    The role of sequential administration of sulphadoxine/pyrimethamine following quinine in the treatment of severe falciparum malaria in children by Ogutu, B. R., Nzila, A. M., Ochong, E., Mithwani, S., Wamola, B., Olola, C. H. O., Lowe, B., Kokwaro, G. O., Marsh, K., Newton, C. R. J. C.

    Published in Tropical medicine & international health (01-05-2005)
    “…Summary Sulphadoxine/pyrimethamine (SP) is often administered with quinine in the treatment of severe falciparum malaria to shorten the course of quinine. The…”
    Get full text
    Journal Article
  3. 3

    Genetic diversity of Plasmodium falciparum parasites from Kenya is not affected by antifolate drug selection by Nzila, A.M, Mberu, E.K, Nduati, E, Ross, A, Watkins, W.M, Sibley, C.H

    Published in International journal for parasitology (01-11-2002)
    “…The genotypes of merozoite surface protein-1, merozoite surface protein-2 and glutamine rich protein are frequently used to distinguish recrudescence from…”
    Get full text
    Journal Article
  4. 4

    The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya by Mberu, E K, Mosobo, M K, Nzila, A M, Kokwaro, G O, Sibley, C H, Watkins, W M

    “…Two clinical trials that used Falcidin (Cosmos Ltd., Nairobi, Kenya), the antifolate combination of pyrimethamine/sulfadoxine (PM/SD), as treatment for…”
    Get more information
    Journal Article
  5. 5

    Pyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next? by Sibley, Carol Hopkins, Hyde, John E, Sims, Paul F.G, Plowe, Christopher V, Kublin, James G, Mberu, Edward K, Cowman, Alan F, Winstanley, Peter A, Watkins, William M, Nzila, Alexis M

    Published in Trends in Parasitology (01-12-2001)
    “…Chemotherapy remains the only practicable tool to control falciparum malaria in sub-Saharan Africa, where >90% of the world's burden of malaria mortality and…”
    Get full text
    Book Review Journal Article
  6. 6

    Characteristics of Plasmodium falciparum dhfr Haplotypes That Confer Pyrimethamine Resistance, Kilifi, Kenya, 1987–2006 by Certain, Laura K., Briceño, Marnie, Kiara, Steven M., Nzila, Alexis M., Watkins, William M., Sibley, Carol Hopkins

    Published in The Journal of infectious diseases (15-06-2008)
    “…Resistance to the antimalarial drug sulfadoxine-pyrimethamine (SP) emerged in Plasmodium falciparum from Asia in the 1960s and subsequently spread to Africa…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Sulfa drugs strike more than once by Patel, Onisha G., Mberu, Eddy K., Nzila, Alexis M., Macreadie, Ian G.

    Published in Trends in parasitology (2004)
    “…Sulfa drugs are well known blockers of folate synthesis, acting as competitive inhibitors of p-aminobenzoate (pABA). Their mimicry of pABA is so complete that…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Therapeutic potential of folate uptake inhibition in Plasmodium falciparum by Nzila, Alexis M., Kokwaro, Gilbert, Winstanley, Peter A., Marsh, Kevin, Ward, Steve A.

    Published in Trends in parasitology (01-03-2004)
    “…Plasmodium falciparum parasites resistant to the combination sulfadoxine–pyrimethamine are spreading in Africa, particularly in East Africa. This is a matter…”
    Get full text
    Journal Article
  11. 11